Erste Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History

Erste Asset Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-27,300	Closed	-$1.28M	–	824
2025 Q2	$1.28M	Hold	27,300	–	–	0.01%	456
2025 Q1	$1.29M	Buy	27,300 +15,000	+122%	+$690K	0.02%	350
2024 Q4	$447K	Hold	12,300	–	–	0.01%	447
2024 Q3	$397K	Hold	12,300	–	–	﹤0.01%	456
2024 Q2	$462K	Hold	12,300	–	–	0.01%	423
2024 Q1	$616K	Hold	12,300	–	–	0.01%	407
2023 Q4	$458K	Hold	12,300	–	–	0.01%	433
2023 Q3	$289K	Hold	12,300	–	–	0.01%	456
2023 Q2	$311K	Hold	12,300	–	–	0.01%	461
2023 Q1	$314K	Hold	12,300	–	–	0.01%	468
2022 Q4	$300K	Hold	12,300	–	–	0.01%	458
2022 Q3	$334K	Hold	12,300	–	–	0.01%	464
2022 Q2	$314K	Hold	12,300	–	–	0.01%	475
2022 Q1	$734K	Hold	12,300	–	–	0.01%	390
2021 Q4	$749K	Hold	12,300	–	–	0.01%	386
2021 Q3	$771K	Hold	12,300	–	–	0.02%	361
2021 Q2	$975K	Hold	12,300	–	–	0.02%	345
2021 Q1	$842K	Hold	12,300	–	–	0.02%	342
2020 Q4	$894K	Buy	+12,300	New	+$792K	0.02%	348

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Erste Asset Management's SWTX Position: Q3 2025 in Review

Erste Asset Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 27,300 shares — an estimated $1.28M sold.

Erste Asset Management first reported a position in SWTX in Q4 2020 and held it in 19 quarters. The position peaked at $1.29M in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Erste Asset Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Erste Asset Management sold 27,300 SpringWorks Therapeutics shares in Q3 2025, an estimated $1.28M.
Erste Asset Management first reported a position in SpringWorks Therapeutics in Q4 2020 and held it in 19 quarters.
Erste Asset Management's SpringWorks Therapeutics position peaked at $1.29M in Q1 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Erste Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.